Holen Sie sich die Stockscreener-App
27.54
2.68%
0.72
Vorhandelsmarkt:
28.98
1.44
+5.23%
Schlusskurs vom Vortag:
$26.82
Offen:
$27.26
24-Stunden-Volumen:
593.79K
Relative Volume:
0.30
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+25.81%
1M Leistung:
+45.87%
6M Leistung:
-46.79%
1J Leistung:
-70.19%
1-Tages-Spanne:
$27.25
$28.09
1-Wochen-Bereich:
$22.30
$28.33
52-Wochen-Spanne:
$16.08
$105.60
Defiance Daily Target 2 X Long Nvo Etf Stock (NVOX) Company Profile
Firmenname
Defiance Daily Target 2 X Long Nvo Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie NVOX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVOX
Defiance Daily Target 2 X Long Nvo Etf
|
27.54 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
340.14 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
689.51 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
692.55 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
269.23 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
620.47 | 124.43B | 0 | 0 | 0 | 0.00 |
Defiance Daily Target 2 X Long Nvo Etf Aktie (NVOX) Neueste Nachrichten
Defiance Daily Target 2X Long NVO ETF (NVOX) Stock Trends and Sentiment 2025 - MarketBeat
U.S. Stock ETF Tracker | The first approved 'oral weight-loss wonder drug' boosts the 2x Long NVO ETF by over 14% - 富途牛牛
Dow Theory LettersDefiance Daily Target 2X Long NVO ETF (NYSE:NVOX) Stock Quote - FinancialContent
Sell on the Pop Prospects: December 17 Edition - ETF Database
Defiance Daily Target 2X Long NVO ETF To Carry Out 1-for-8 Reverse Stock Split On December 9th, 2025 - 富途牛牛
Tidal Financial Group and Defiance ETFs Announce Reverse Stock Splits for Select Leveraged ETFs - The Manila Times
NVOX Stock Institutional Owners - Quiver Quantitative
Super Micro Shares Fall 9% After Earnings Miss, Soft EPS Outlook - 富途牛牛
Super Micro Raises Revenue Outlook as Order Book Expands - 富途牛牛
Super Micro Computer Fiscal Q1 Adjusted Earnings, Revenue Fall; Issues Q2 Guidance, Raises 2026 Revenue Outlook - 富途牛牛
U.S. Equity ETF Tracker | Cryptocurrency-related stocks fell collectively, while the 2x inverse MSTR ETF surged 15% - 富途牛牛
From '2x Leveraged' to 'Inverse Decline,' Are Leveraged ETFs Living Up to Their Names? - 富途牛牛
Defiance Launches QSU: The First 2X Long ETF for QuantumScape Corporation - Yahoo Finance
MSTX: An Aggressive Strategy & Bitcoin Bet (NASDAQ:MSTX) - Seeking Alpha
Broadcom-OpenAI collaboration sends these ETFs higher - Seeking Alpha
Super Micro Computer Options Spot-On: On October 10th, 419.95K Contracts Were Traded, With 2.55 Million Open Interest - 富途牛牛
MSTU: Don't Play With Fire (BATS:MSTU) - Seeking Alpha
Bernstein Initiates Super Micro Computer(SMCI.US) With Hold Rating, Announces Target Price $46 - 富途牛牛
U.S. Stock ETF Tracker | Quantum concept stocks surged strongly, with the 2x Long IONQ ETF skyrocketing 36% and the 2x Long RGTI ETF surging nearly 33%; Tesla continued to rise over 7%, while the 2x Short TSLA ETF plummeted more than 15%. - 富途牛牛
Defiance Has A New ETF For High-Stakes Pharma Traders - inkl
Defiance Launches ZYN: 2X Long ETF for Philip Morris International Inc. - Yahoo Finance
N-PX: Others - 富途牛牛
Novo Nordisk Plunges 2.6% Amid Legal Storm and Rival Drug Data – What’s Next for NVO? - AInvest
Novo Nordisk Surges 2.8% on Strategic Wins and Legal Clampdowns – What’s Fueling the Rally? - AInvest
Big Tech Woes Power Surge in Inverse Single-Stock ETFs - Nasdaq
Novo Nordisk Surges 2.46% Amid Leadership Shift and Sector Volatility – What’s Fueling the Rally? - AInvest
Eli Lilly Surges 3.36% Amid UK Price Hike and AI-Driven Obesity Deal: What’s Fueling the Rally? - AInvest
Eli Lilly Surges 3% on Insider Buying and Regulatory Drama – What’s Next? - AInvest
Novo Nordisk Surges 4.7% Amid Obesity Drug Rivalry: Is This the New Benchmark? - AInvest
Sarepta Soars 8.55% on Earnings & FDA Greenlight: Can This Biotech Rebound Sustain Momentum? - AInvest
NVO's 6.37% Surge: A Bullish Rebound Amid Earnings Volatility and Sector Shifts - AInvest
Eli Lilly Plummets 3% as Sector Turmoil and Rival Struggles Ignite Selling Frenzy - AInvest
Novo Nordisk Plummets 3.87% Amid Earnings Woes and Sector Headwinds – What’s Next for the GLP-1 Giant? - AInvest
Novo Nordisk Plunges 3.45%: Is This the Bottom or a Deeper Downtrend? - AInvest
US ETF Tracker | Trump imposes a 50% tariff on imported semi-finished copper, causing the United Sts Commodity Index Fd Com Unit Repstg U S Copper Index Fd to plummet by nearly 20%; the 2x leveraged MRVL ETF rises by almost 14% - 富途牛牛
Will drop go up or down throughout this week - AInvest
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - Yahoo Finance
Novo Nordisk Plunges 20.4%, What’s Next for the Pharma Giant? - AInvest
Novo Nordisk Crashes 20.02%—Is This a Buying Opportunity or a Warning Sign? - AInvest
Novo Nordisk Skyrockets 4.78%—What’s Fueling This High-Stakes Surge? - AInvest
DeFiance Daily Target 2X Long Nvo ETF (NVOX-A) Profile - The Globe and Mail
Novo Nordisk Skyrockets 2.71% Intraday—Is This the Dawn of a New Obesity Drug Era? - AInvest
U.S. ETF Tracking | Online Car-hailing giant Uber Technologies will invest $300 million in electric car manufacturer Lucid, leading to a 73% surge in the 2x leveraged LCID ETF; the 2x leveraged QBTS ETF rose by over 27%. - 富途牛牛
SMCX: The High-Octane ETF That’s Crushing (Or Crashing) Investors (NASDAQ:SMCX) - Seeking Alpha
Wall Street's top and bottom 20 performing ETFs YTD as H1 concludes - Seeking Alpha
HIMZ: Buy For Short-Term Gains On Hims & Hers Health, But Be Wary Of The Risks (NASDAQ:HIMZ) - Seeking Alpha
HIMS Leveraged ETF Crashes 70% as Novo Ends Deal - ETF.com
Defiance Launches CVNX: The First 2X Long ETF for Carvana Co. - Yahoo Finance
ETF Spotlight: HIMZ on the Rise After Wegovy Hookup - ETF.com
5 Single-Stock ETFs That Doubled in a Month - Nasdaq
Tidal to implement 1-for-20 reverse stock split for 2x short MSTR fund - MSN
Finanzdaten der Defiance Daily Target 2 X Long Nvo Etf-Aktie (NVOX)
Es liegen keine Finanzdaten für Defiance Daily Target 2 X Long Nvo Etf (NVOX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):